MedPath

Effects of Female Sex Hormones over the Course of the Menstrual Cycle on Optimal CPAP Pressures Used in the Treatment of Obstructive Sleep Apnoea

Not Applicable
Recruiting
Conditions
Obstructive Sleep Apnoea
Respiratory - Sleep apnoea
Registration Number
ACTRN12606000461594
Lead Sponsor
Institute for Breathing and Sleep
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
20
Inclusion Criteria

Pre-menopausal.

Exclusion Criteria

Other sleep disorderMenstrual cycle disorderTreatment with oral hormone replacementSevere medical, psychological or psychiatric co-morbidities.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observing any changes in CPAP pressure requirement over five weeks (one menstrual cycle). Estimated that this will occur during the early Luteal phase of the menstrual cycle. The Luteal phase is defined as the period of time following the mid-cycle surge in Luteinising Hormone, and is associated with ovulation. The Luteal phase ends at the beginning of the following menses (menstrual period).[Over five weeks (one menstrual cycle).]
Secondary Outcome Measures
NameTimeMethod
Patients will be required to note any changes in their normal daily activities as well as medication and alcohol or caffeine intake, in a daily journal supplied by the investigators for 5 weeks, to evaluate if there are any confounding factors that would affect airway patency, sleep quality or core body temperature.[]
© Copyright 2025. All Rights Reserved by MedPath